Morning Overview on MSN
A new genomic test could spare two-thirds of high-risk breast cancer patients from chemotherapy entirely, per ASCO 2026 results
Thousands of women diagnosed with high-risk, estrogen-receptor-positive breast cancer may no longer need chemotherapy, ...
From IVF clinics to premarital counselling, genetic compatibility testing is becoming part of modern family planning ...
A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...
Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...
A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet ...
The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...
Chemotherapy decisions for young women with HR+ breast cancer and low recurrence scores reveal testing disparities that health systems must address. AJMC: Your analysis focused on chemotherapy use ...
(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...
Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...
Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...
The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results